IRVINE, Calif., Aug. 29, 2011 /PRNewswire/ — Masimo (NASDAQ:
MASI) today announced that its management is scheduled to
present at the Morgan Stanley Global Healthcare Conference at the
Grand Hyatt New York on Tuesday, September 13, 2011, at 1:35 p.m.
Eastern Time. A live audiocast of the presentation will be
available on the Masimo website at www.masimo.com.
A replay of the audiocast will be available following the
live presentation.
About Masimo Masimo (NASDAQ:
MASI) develops innovative monitoring technologies that
significantly improve patient care—helping solve “unsolvable”
problems. In 1995, the company debuted Measure-Through Motion
and Low Perfusion pulse oximetry, known as Masimo SET®, which
virtually eliminated false alarms and increased pulse oximetry’s
ability to detect life-threatening events. More than 100
independent and objective studies demonstrate Masimo SET provides
the most reliable SpO2 and pulse rate measurements even under the
most challenging clinical conditions, including patient motion and
low peripheral perfusion. In 2005, Masimo introduced
rainbow® Pulse CO-Oximetry™, allowing noninvasive and
continuous monitoring of blood constituents that previously
required invasive procedures, including total hemoglobin
(SpHb®), oxygen content (SpOC™), carboxyhemoglobin
(SpCO®), methemoglobin (SpMet®), and Pleth Variability
Index (PVI®), in addition to SpO2, pulse rate, and perfusion
index (PI). In 2009, Masimo introduced rainbow Acoustic
Monitoring™, the first-ever noninvasive and continuous
monitoring of acoustic respiration rate (RRa™).
Masimo’s rainbow SET platform offers a breakthrough in
patient safety by helping clinicians detect life-
‘/>”/>
SOURCE
